Holdings (40)
| Name | Sector | Instrument | Assets |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | Healthcare | Equity | 10.08156982% |
| Cipla Ltd. | Healthcare | Equity | 5.48246482% |
| Ajanta Pharma Ltd. | Healthcare | Equity | 4.91999247% |
| Procter & Gamble Health Ltd. | Healthcare | Equity | 4.29692139% |
| Dr. Reddy's Laboratories Ltd. | Healthcare | Equity | 4.20484919% |
| Glenmark Pharmaceuticals Ltd. | Healthcare | Equity | 3.99061475% |
| Lupin Ltd. | Healthcare | Equity | 3.52779627% |
| Apollo Hospitals Enterprise Ltd. | Healthcare | Equity | 3.49344668% |
| Divi's Laboratories Ltd. | Healthcare | Equity | 3.47074718% |
| Fortis Healthcare Ltd. | Healthcare | Equity | 3.36253777% |
Returns and rankings
| 1Y | 3Y | 5Y | All | |
|---|---|---|---|---|
| Fund Returns | 12.07% | 26.62% | 20.91% | 14.85% |
| Category Average | 6.89% | 22.67% | 19.03% | NA% |
| Rank Within Category | 5.00% | 2.00% | 4.00% | NA% |
Expense ratio, exit load and tax
Expense ratio: 1.26%
Inclusive of GST
Exit load
Exit load of 1% if redeemed within 30 days.
Stamp duty
0.005% (from July 1st, 2020)
Tax implication
If you redeem within one year, returns are taxed at 20%. If you redeem after one year, returns exceeding Rs 1.25 lakh in a financial year are taxed at 12.5%.
Fund management
Education
Mr. Gada is B.com, CA, CS, & CFA
Experience
Prior to joining UTI Mutual Fund he has worked with BPCL as Senior Accounts Officer.